- Stryker (NYSE: SYK) announced yesterday that the board of directors approved leadership and committee assignment changes. These are the details.
Stryker (NYSE: SYK) announced yesterday that the company’s board of directors approved board leadership and committee assignment changes, naming Sherilyn McCoy to replace Allan Golston as Lead Independent Director, and Mary K. Brainerd to replace Ms. McCoy as Chair of the Governance and Nominating Committee.
Golston has been a member of Stryker’s Board of Directors since 2011 and has served as Lead Independent Director since 2016 and Chair of the Compensation Committee since 2021.
McCoy has been a member of Stryker’s Board of Directors since 2018 and has served as Chair of the Governance and Nominating Committee since 2019. And Brainerd has been a member of Stryker’s Board of Directors since 2017 and has served on each of the board committees during her tenure.
The board leadership and committee assignments are now as follows below:
— Chair of the Board – Kevin A. Lobo
— Lead Independent Director – Sherilyn S. McCoy
— Audit Committee – Andrew K. Silvernail (Chair), Srikant M. Datar, Lisa M. Skeete Tatum and Rajeev Suri
— Compensation Committee – Allan C. Golston (Chair), Mary K. Brainerd, Giovanni Caforio and Sherilyn S. McCoy
— Governance and Nominating Committee – Mary K. Brainerd (Chair), Giovanni Caforio, Allan C. Golston, Sherilyn S. McCoy and Ronda E. Stryker
“Allan has provided strong leadership for our independent directors and has helped us build a highly effective and diverse board.”
“We are proud to have independent directors with varied experiences, perspectives, and talents serving on our board. Stryker is committed to diversity and board refreshment, including rotation of committee chair assignments, which enhances our ability to support our customers to make healthcare better.”
— Kevin A. Lobo, Chair & Chief Executive Officer